Healthcare provider profile · identity verified

Elvin Vigo Paredes, M.D.

General Practice · ANASCO, PR · NPI 1962552349

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Losartan Potassium	Losartan Potassium	591	86
Rosuvastatin Calcium	Rosuvastatin Calcium	554	83
Metformin Hcl	Metformin Hcl	421	61
Levothyroxine Sodium	Levothyroxine Sodium	400	54
Lisinopril	Lisinopril	400	55
Atorvastatin Calcium	Atorvastatin Calcium	397	70
Amlodipine Besylate	Amlodipine Besylate	376	54
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	250	40
Gabapentin	Gabapentin	246	49
Simvastatin	Simvastatin	212	33
Alprazolam	Alprazolam	201	42
Glipizide	Glipizide	198	28
Omeprazole	Omeprazole	197	36
Tamsulosin Hcl	Tamsulosin Hcl	185	27
Hydrochlorothiazide	Hydrochlorothiazide	182	28
Fluoxetine Hcl	Fluoxetine Hcl	158	28
Clonazepam	Clonazepam	156	26
Metoprolol Succinate	Metoprolol Succinate	151	27
Famotidine	Famotidine	139	29
Alendronate Sodium	Alendronate Sodium	132	21
Donepezil Hcl	Donepezil Hcl	117	17
Synthroid	Levothyroxine Sodium	111	18
Finasteride	Finasteride	102	16
Trazodone Hcl	Trazodone Hcl	98	19
Clopidogrel	Clopidogrel Bisulfate	96	14
Carvedilol	Carvedilol	95	14
Glimepiride	Glimepiride	86	15
Sertraline Hcl	Sertraline Hcl	85	13
Buspirone Hcl	Buspirone Hcl	78	15
Pantoprazole Sodium	Pantoprazole Sodium	71	15
Albuterol Sulfate Hfa	Albuterol Sulfate	66	17
Prednisone	Prednisone	66	39
Metoprolol Tartrate	Metoprolol Tartrate	61	suppressed
Humulin N	Insulin Nph Human Isophane	59	11
Nifedipine Er	Nifedipine	58	suppressed
Atenolol	Atenolol	57	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	54	suppressed
Naproxen	Naproxen	52	36
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	51	15
Meclizine Hcl	Meclizine Hcl	49	20
Montelukast Sodium	Montelukast Sodium	48	16
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	47	suppressed
Enalapril Maleate	Enalapril Maleate	46	suppressed
Hydralazine Hcl	Hydralazine Hcl	46	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	46	suppressed
Verapamil Er	Verapamil Hcl	45	suppressed
Diclofenac Sodium	Diclofenac Sodium	44	26
Furosemide	Furosemide	44	suppressed
Spironolactone	Spironolactone	44	suppressed
Gemfibrozil	Gemfibrozil	42	suppressed
Mirtazapine	Mirtazapine	41	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	39	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	38	suppressed
Irbesartan	Irbesartan	37	suppressed
Dexamethasone	Dexamethasone	35	31
Lorazepam	Lorazepam	35	suppressed
Bupropion Xl	Bupropion Hcl	34	suppressed
Paroxetine Hcl	Paroxetine Hcl	34	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	33	suppressed
Tramadol Hcl	Tramadol Hcl	31	19
Zolpidem Tartrate	Zolpidem Tartrate	28	suppressed
Advocate Syringes	Syringe-Needle,insulin,0.5 Ml	26	suppressed
Terazosin Hcl	Terazosin Hcl	26	suppressed
Xarelto	Rivaroxaban	26	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	24	suppressed
Theophylline Er	Theophylline Anhydrous	24	suppressed
Allopurinol	Allopurinol	23	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	23	11
Risperidone	Risperidone	23	suppressed
Methylprednisolone	Methylprednisolone	22	22
Pravastatin Sodium	Pravastatin Sodium	22	suppressed
Tizanidine Hcl	Tizanidine Hcl	22	17
Amiodarone Hcl	Amiodarone Hcl	21	suppressed
Clonidine Hcl	Clonidine Hcl	20	suppressed
Duloxetine Hcl	Duloxetine Hcl	20	suppressed
Advocate Syringes	Syringe And Needle,insulin,1ml	19	suppressed
Azithromycin	Azithromycin	19	16
Diclofenac Potassium	Diclofenac Potassium	19	12
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	19	suppressed
Nabumetone	Nabumetone	19	16
Ramipril	Ramipril	19	suppressed
Sure Comfort	Syringe And Needle,insulin,1ml	19	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	18	suppressed
Meloxicam	Meloxicam	18	suppressed
Mesalamine	Mesalamine	18	suppressed
Memantine Hcl	Memantine Hcl	17	suppressed
Latanoprost	Latanoprost	16	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	16	suppressed
Metformin Hcl Er	Metformin Hcl	15	suppressed
Valsartan	Valsartan	15	suppressed
Fluticasone Propionate	Fluticasone Propionate	14	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	14	suppressed
Sure Comfort	Syringe-Needle,insulin,0.5 Ml	14	suppressed
Temazepam	Temazepam	14	suppressed
Bethanechol Chloride	Bethanechol Chloride	13	suppressed
Captopril	Captopril	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	12
Citalopram Hbr	Citalopram Hydrobromide	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	13
Aripiprazole	Aripiprazole	12	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	12	suppressed
Mometasone Furoate	Mometasone Furoate	12	suppressed
Carbamazepine Er	Carbamazepine	11	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	11	suppressed
Desmopressin Acetate	Desmopressin (Nonrefrigerated)	11	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Estazolam	Estazolam	11	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	11	suppressed
Mounjaro	Tirzepatide	11	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error